---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-209020"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:03:02.204240+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Invivyd reports Q2 net loss $50.2M; plans pivotal VYD222 trial for COVID-19 prevention

## Summary
- Net loss of $50.2M ($0.46 per share) vs. $51.0M ($0.47) in Q2 2022; revenue none.
- Cash & equivalents $298.4M; runway into Q4 2024, excluding potential product revenue.
- Plans to initiate CANOPY pivotal trial of VYD222 (~750 participants) using Day 28 neutralizing titers as surrogate endpoint for EUA.
- Phase 1 data showed favorable safety and robust neutralizing titers against Omicron XBB.1.5 at all three doses tested.
- FDA alignment on immunobridging approach for EUA; expects initial CANOPY data by end of 2023.

## SEC filing metadata
- accession: 0001193125-23-209020
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312523209020/0001193125-23-209020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312523209020/d480890d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-209020
- JSON: https://secwatch.observer/filing/0001193125-23-209020.json
- Plain text: https://secwatch.observer/filing/0001193125-23-209020.txt

## Key facts
- Earnings Releases
  Invivyd, Inc. reported financial results for quarter ended June 30, 2023.
  - Period: quarter ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, Invivyd, Inc. (the “Company”) issued a press release providing a corporate update and announcing its financial results for the quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832038/000119312523209020/0001193125-23-209020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.